AMAG Pharma (AMAG) Reports Q4 Loss of $5.89/Share
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Total costs and expenses: 105.02M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total costs and expenses: 105.02M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q4 EPS of ($5.89), versus ($0.60) reported last year. Revenue for the quarter came in at $89.7 million, versus $88.1 million reported last year.
GUIDANCE:
AMAG Pharma sees FY2020 revenue of $230-280 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
